Guardant Health, Inc.
Guardant Health, Inc.（GH）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
gh · 股价预测 · 30 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 30 位华尔街分析师
Buy
30 位分析师
共识
评级分布
12 个月目标价
High
$175
Consensus
$143
+12.2% upside
Low
$115
Median: $135 · Last Close: $127.37
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$142.93
12.2% upside
High Target
$175
37.4%
Low Target
$115
-9.7%
Current Price
$127.37
as of today
Based on analyst price targets, the GH stock price prediction for the next 12 months ranges from $115 to $175. The consensus GH price forecast of $142.93 implies 12.2% upside from the current price of $127.37.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $133.74 | ↑ 5.00% |
1-day model range: $132.66–$134.82. Peak: $134.82 (+5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $166 | +30.3% |
| 2028 | $199 | +56.0% |
| 2029 | $224 | +76.0% |
| 2030 | $243 | +90.6% |
| 2031 | — | +100.9% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · GH · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-05 | Goldman Sachs | Maintains | Buy→Buy |
| 2026-06-02 | Evercore ISI Group | Upgrade ↑ | In Line→Outperform |
| 2026-05-27 | BTIG | Maintains | Buy→Buy |
| 2026-05-26 | BTIG | Maintains | Buy→Buy |
| 2026-05-08 | Evercore ISI Group | Maintains | In Line→In Line |
| 2026-05-08 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-05-08 | Barclays | Maintains | Overweight→Overweight |
| 2026-04-14 | Barclays | Maintains | Overweight→Overweight |
| 2026-04-06 | Evercore ISI Group | Maintains | In Line→In Line |
| 2026-02-24 | Piper Sandler | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Guardant Health, Inc. (GH) stock. Of the recent 167 rating actions, 8 were upgrades and 4 were downgrades. 30 analysts currently cover GH.
分析师推荐趋势
GH analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 9 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1.3B
↓ 39.4% YoY
Revenue Next Year
$1.7B
↑ 28.9% YoY
EPS This Year
$-2.93
EPS Next Year
$-2.02
↓ 31.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast GH EPS of $-2.93 for the current fiscal year, based on estimates from 11 analysts. The GH revenue forecast is $1.3B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
GH 股价预测由两类独立数据源支撑：来自 30 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。GH 的共识目标价为 $142.93（+12.2% 上行空间），分析师共识为 Buy。
GH 的短期预测（明日）为 $133.74（+5.00%）。 GH 对 2027 年的股价预测均值为 $166。 GH 对 2030 年的预测区间为 $221–$264。
Guardant Health, Inc. 在 NASDAQ 上市，代码 GH。GH 在 2027 年的整体展望偏积极，在覆盖分析师中约 97% 对应 Buy 共识。
常见问题
GH 预测 · 8 个问题根据 30 位华尔街分析师，GH 的 12 个月平均目标价为 $142.93，最高 $175.00、最低 $115.00。若有图表，中位目标价可在上方查看。相对当前价 $127.37，隐含约 +12.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.